Butterfly iQ3 Ultrasound System vs Fibresolve (with PCCP)

The Butterfly iQ3 is designed for point-of-care use with a handheld, ergonomic probe and seamless mobile integration, allowing for quick scans and interpretations. Its configurable buttons and magnetic charging system enhance user convenience and streamline workflows. Fibresolve, while designed for integration-free workflow, is a cloud-based service that analyzes CT scans, which implies a less immediate and interactive user experience compared to a handheld ultrasound device.

The Butterfly iQ3 offers whole-body imaging with a single probe for over 20 clinical applications, including AI-powered tools for enhanced diagnostic confidence across various specialties. Fibresolve is an AI-driven diagnostic tool specifically for lung fibrosis, providing diagnostic subtype classification and adjunctive information for clinicians, which has been shown to increase IPF diagnoses and reduce invasive procedures in specific cases. While Fibresolve offers significant value in its niche, the broader applicability and real-time diagnostic capabilities of the Butterfly iQ3 give it a slight edge in overall clinical value.

The Butterfly iQ3 has transparent pricing with a clear upfront cost for the probe and annual subscription tiers. Fibresolve requires contacting the vendor for pricing, which can make it harder to assess its overall value proposition without direct engagement. The Butterfly iQ3's published pricing and comprehensive features for its cost offer a more straightforward value assessment.

The Butterfly iQ3 offers seamless integration with EMR/PACS systems via a DICOM connector and Butterfly Cloud, along with workflow management software and reporting tools, making it suitable for clinic-level and institutional deployments. Fibresolve is a cloud-based centralized service designed for integration-free workflow and has CPT billing codes, which supports its adoption in clinical settings. However, Butterfly iQ3's explicit mention of EMR/PACS integration and enterprise bundles suggests a more mature offering for large-scale deployments.

The Butterfly iQ3 features advanced Ultrasound-on-Chipu2122 technology, a single probe for whole-body imaging, and several AI-powered imaging tools like iQ Sliceu2122 and iQ Fanu2122. Fibresolve is also innovative as an FDA-authorized AI diagnostic tool for lung fibrosis that analyzes standard CT scans and has a Breakthrough Designation. However, the Butterfly iQ3's proprietary chip technology and broad application across numerous specialties represent a more foundational technological innovation in the ultrasound space.

Both tools are FDA-cleared, implying a certain level of documentation and regulatory compliance. Butterfly Network provides educational tools and tutorials through Butterfly Academy. Imvaria highlights that Fibresolve was built by medical doctors with software engineering expertise and is designed for ease of use. Without specific details on the breadth and depth of support resources for Fibresolve, it is difficult to definitively choose a winner, resulting in a tie.